European Archives - Page 246 of 1003 - European Medical Journal

Precision Medicine in Airway Diseases: What Can We Offer in the Clinic?

Sanjay Haresh Chotirmall, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, began the session…

Exploring Type 2 Inflammation in Chronic Obstructive Pulmonary Disease

Rabe began the presentation by highlighting two hypothetical patients with different ages, physiologies, and backgrounds to contextualise…

Efficiency Assessment of 15 Nebuliser Systems by the Respirable Drug Delivery Rate: A Comparable Quality Parameter

Nebuliser therapy is a relevant therapy option for respiratory diseases, yet studies have demonstrated a wide variation in nebuliser drug…

Biofilms and Innovations in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a leading cause of death. This review focuses on the development of biofilms, and…

Non-invasive Management of Atelectasis: A Case Report

The manuscript describes the physiotherapeutic techniques used and collects the main scientific evidence on them. The main purpose…

Anatomical Variant of the Right Upper Lobe Bronchus

The authors present a case of a 77-year-old female, a former smoker with a history of chronic obstructive pulmonary disease who underwent…

Dr Andreas Konieczny on leading with authenticity

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.

Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny

In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!

A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)

Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.

Inflammatory-Related Diseases an Early Sign of Type 2 Diabetes?

The present study assessed the clinical histories of pre- and post-Type 2 Diabetes diagnoses with the aim of gaining insight into causes and trajectories for health-related conditions, such as cardiovascular and pulmonary disorders.